Human CellExp ErbB1/EGFR, mouse recombinant protein
EGFR, ERBB, ERBB1, HER1, PIG61, mENA
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q01279 |
---|---|
Calculated MW | This protein has a C-terminal 6×His tag and has a calculated MW of 70 kDa. The predicted N-terminus is Leu 25. In DTT-reduced SDS-PAGE, protein migrates as 110-115 kDa. |
Gene ID | 13649 |
---|---|
Gene Symbol | EGFR |
Other Names | EGFR, ERBB, ERBB1, HER1, PIG61, mENA |
Gene Source | Mouse |
Source | HEK293 cells |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | N/A; |
Recombinant | Yes |
Results | Measured by its binding ability in a functional ELISA. Immobilized mouse EGF at 10 µg/ml can bind mouse EGFR with a linear range of 2.5–1000 ng/ml. |
Target/Specificity | ErbB1 |
Application Notes | Centrifuge the vial prior to opening. Reconstitute in sterile PBS, pH 7.4 to a concentration of 50 µg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 month. For extended storage, it is recommended to store at -20°C. |
Format | Lyophilized |
Storage | -20°C; Lyophilized from 0.22 µm filtered solution in PBS, pH7.4. Generally 5-8% Mannitol or trehalose is added as a protectant before lyophilization. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The epidermal growth factor receptor (EGFR; ErbB-1; HER1) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.
References
Avivi A.,et al.Oncogene 7:1957-1962(1992).
Paria B.C.,et al.Proc. Natl. Acad. Sci. U.S.A. 90:55-59(1993).
Hibbs M.L.,et al.Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases.
Luetteke N.C.,et al.Genes Dev. 8:399-413(1994).
Avivi A.,et al.Oncogene 6:673-676(1991).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.